1006OCopanlisib monotherapy activity in relapsed or refractory indolent B-cell lymphoma: Combined analysis from phase I and II studies. (23rd October 2018) - Zinzani, P L; Santoro, A; Mollica, L; Follows, G A; Bouabdallah, K; Morschhauser, F; Patnaik, A; Huang, L; Hiemeyer, F; Benson, A; Genvresse, I; Garcia-Vargas, J E; et al.